Pfizer, UCSF expand scope of drug research deal

Pfizer Inc. and UCSF will expand a 2-1/2-year-old drug-research deal to include small molecules, making it possibly the only academic-industry research collaboration encompassing oral small-molecule drugs as well as large-molecule biologics...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.